Arrhythmias as a Complication of Chemotherapy

dc.contributor.authorErgashov Bobir Bahodirovich
dc.date.accessioned2025-12-31T12:15:26Z
dc.date.issued2023-08-30
dc.description.abstractThe proposed review examines rhythm disturbances by the type of tachyarrhythmias, most often found in cancer patients, as well as their features, characteristic directly for oncological diseases, and emphasizes the importance of ECG monitoring for early diagnosis, treatment and monitoring of this cohort of patients who are more susceptible to the development of proarrhythmia. Oncologists should be fully aware of possible cardiac arrhythmias, and close cooperation between cardiologists and oncologists will lead to better stratification of the risk of developing cardiovascular diseases, monitoring and treatment.
dc.formatapplication/pdf
dc.identifier.urihttps://scholarsdigest.org/index.php/ijsnms/article/view/372
dc.identifier.urihttps://asianeducationindex.com/handle/123456789/44885
dc.language.isoeng
dc.publisherScholars Digest Publishing
dc.relationhttps://scholarsdigest.org/index.php/ijsnms/article/view/372/365
dc.sourceInternational Journal of Studies in Natural and Medical Sciences; Vol. 2 No. 8 (2023); 40-51
dc.source2949-8848
dc.source2949-8953
dc.subjectoncology, chemotherapy, arrhythmogenic effect, supraventricular tachycardia, ventricular tachycardia, cardioncology, cardiotoxicity.
dc.titleArrhythmias as a Complication of Chemotherapy
dc.typeinfo:eu-repo/semantics/article
dc.typeinfo:eu-repo/semantics/publishedVersion
dc.typePeer-reviewed Article

item.page.files

item.page.filesection.original.bundle

pagination.showing.labelpagination.showing.detail
loading.default
thumbnail.default.alt
item.page.filesection.name
bahodirovich_2023_arrhythmias_as_a_complication_of_chemoth.pdf
item.page.filesection.size
223.23 KB
item.page.filesection.format
Adobe Portable Document Format

item.page.collections